Primary Sjögren's disease is primarily driven by B-cell activation and is associated with a
high risk of developing non-Hodgkin's lymphoma (NHL). Over the last few decades …

S-17 periepithelial inflammatory infiltrate such as B and T cells. In the era of biotechnologic
revolution, the necessity to discover novel biomarkers for pSS and define clinically useful …

Objectives Development of non-Hodgkin's lymphoma (NHL) is the major adverse outcome of
Sjögren's syndrome (SS) affecting both morbidity and mortality. Preliminary evidence …

Background Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune disease
of the exocrine glands characterized by specific pathological features. Previous studies have …

Background While all salivary glands (SGs) can be involved in primary Sjögren's syndrome
(pSS), their respective role in pathogenesis remains unclear. Our objective was to assess …

Sjögren's syndrome (SS) is a complex autoimmune disease associated with lymphocytic
infiltration and secretory dysfunction of salivary and lacrimal glands. Although the etiology of …

Sjögren's syndrome (SS) is a complex autoimmune disease associated with lymphocytic
infiltration and secretory dysfunction of salivary and lacrimal glands. Although the etiology of …

Abstract Aim Primary Sjögren's syndrome (pSS) is an autoimmune disease affecting
exocrine glands. Both autoreactive T cells and B cells are involved in the development of …

Sjögren's syndrome (SS) is characterized by B cell hyperactivity documented by the
production of plethora of autoantibodies and a strong tendency for NHL of B cell origin …

Background In the last years human proteomic has represented a promising tool to promote
the communication between basic and clinical science. Methods To explore the …